| pubmed-article:15983391 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C0153690 | lld:lifeskim |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C0005974 | lld:lifeskim |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C0012544 | lld:lifeskim |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C0257685 | lld:lifeskim |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C1514307 | lld:lifeskim |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C1522492 | lld:lifeskim |
| pubmed-article:15983391 | lifeskim:mentions | umls-concept:C2267018 | lld:lifeskim |
| pubmed-article:15983391 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:15983391 | pubmed:dateCreated | 2005-7-29 | lld:pubmed |
| pubmed-article:15983391 | pubmed:abstractText | Three large, randomized trials of patients with bone metastases recently demonstrated that zoledronic acid reduces the risk of skeletal-related events. These trials provide an opportunity for investigating the correlation between bone metabolism and clinical outcome during bisphosphonate therapy. | lld:pubmed |
| pubmed-article:15983391 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15983391 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15983391 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15983391 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15983391 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15983391 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15983391 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15983391 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15983391 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15983391 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:15983391 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:SmithMatthewM | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:LiptonAllanA | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:ZhengMingM | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:BrownJanet... | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:ColemanRobert... | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:SaadFredF | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:SeamanJohnJ | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:MajorPierreP | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:CookRichardR | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:LeeKer-AiKA | lld:pubmed |
| pubmed-article:15983391 | pubmed:author | pubmed-author:HeiYong... | lld:pubmed |
| pubmed-article:15983391 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15983391 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15983391 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:15983391 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15983391 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15983391 | pubmed:pagination | 4925-35 | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:meshHeading | pubmed-meshheading:15983391... | lld:pubmed |
| pubmed-article:15983391 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15983391 | pubmed:articleTitle | Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid. | lld:pubmed |
| pubmed-article:15983391 | pubmed:affiliation | Yorkshire Cancer Research Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield S10 2SJ, England, UK. r.e.coleman@sheffield.ac.uk | lld:pubmed |
| pubmed-article:15983391 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15983391 | lld:pubmed |
